Novartis is recalling about 73,000 blister packages of Sandimmune (cyclosporine) 100 mg and Neoral (cyclosporine) 100 mg soft gelatin capsules. The drug packaging fails to meet child-resistant requirements, which could allow children to access and ingest the medication. These prescription drugs were sold at clinics and pharmacies nationwide between March 2018 and March 2020. Consumers can continue to use their medication as directed but must take immediate steps to secure it.
The packaging is not child-resistant, posing a serious risk of accidental poisoning if the capsules are swallowed by young children. No injuries or incidents have been reported to date.
Consumers should immediately secure the product out of the sight and reach of children and contact the firm to request a free child-resistant pouch in which to store the blister package medications. Consumers can continue to use the medication as directed. The child-resistant pouches should be used to store these medications until new child-resistant blister packaging is available.
Recalled Neoral® 100 mg soft gelatin capsules
Recalled Sandimmune® 100 mg soft gelatin capsules
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: CPSC Notice · Raw API Response